Plutux
$9.97
+0.25%
2026-09-04 11:27:20 EDT+$0.00
Servicios financieros
Empresas pantalla
NASDAQ
Negociación activa

Averin Capital Acquisition Corp. (ACAA) funciona como una sociedad de adquisición de propósito específico (SPAC), creada específicamente para perseguir una combinación de ...

Evolución del precio

$9.97
+0.00%+$0.00
Máximo
Mínimo
Máx. 52s-2.6%
Vol. rel.
Intervalo
Rango35m
VolumenSMA5SMA10
Averin Capital Acquisition Corp. (ACAA) is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands on October 17, 2025, with operations headquartered in New York City. The company was formed with the sole purpose of effecting a business combination, which may involve a merger, stock exchange, asset acquisition, ...Averin Capital Acquisition Corp. (ACAA) is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands on October 17, 2025, with operations headquartered in New York City. The company was formed with the sole purpose of effecting a business combination, which may involve a merger, stock exchange, asset acquisition, share purchase, or similar transaction with one or more operating businesses. It focuses on acquiring a company at the intersection of technology and health, leveraging the expertise of its management team and sponsor, Averin Capital LLC, a multi-stage investment firm. The company's CEO, David A. Berry, brings over two decades of experience in healthcare and technology innovation. ACAA completed its initial public offering (IPO) on February 19, 2026, raising $250 million by selling 25 million units at $10.00 per unit. The units began trading on the NASDAQ Global Market under the ticker 'ACAAU', and later the shares and warrants separated. As of the latest data, the company has a market capitalization of approximately $356 million, with a stock price of $9.99. It has minimal operational expenses and negative operating cash flow, typical for a SPAC before a business combination. The company employs only 3 full-time employees, focusing on identifying and executing a target acquisition within the allowed time frame (24 months plus possible extensions). Financial metrics show a price-to-book ratio of ~1.05 and negative enterprise value to EBITDA, reflecting pre-transaction status. The company's goal is to deliver value to shareholders by acquiring high-growth businesses in the health-tech sector, potentially benefiting from secular trends in digital health, biotechnology, and AI-driven medical solutions.
Fundación
2025
Empleados
3
CEO
David A. Berry
Nombre completo
Averin Capital Acquisition Corp.
Sector
Servicios financieros
Industria
Empresas pantalla
ROE
1.15%
Capitalización
$0.36B
Ratio corriente
3.25
ROIC
-122.64%

Información de contacto

1 339 234-9160
240 West 40th Street, New York, NY 10018

Acciones relacionadasShell Companies

Ver todas las acciones de EE. UU.

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal

© Plutux Technology Limited 2026